Showing 2411-2420 of 3189 results for "".
Seeing the Spectrum: Recognizing Lichen Planus in Various Skin Types
https://practicaldermatology.com/youngmd-connect/resident-resource-center/seeing-the-spectrum-recognizing-lichen-planus-in-various-skin-types/23393/How Lichen Planus presents in various skin types and tips on differential diagnosis.The Effect of Cleansers on the Skin Microbiome
https://practicaldermatology.com/youngmd-connect/resident-resource-center/the-effect-of-cleansers-on-the-skin-microbiome/23269/Leadership Without Authority:Influencers of Culture in Your Practice
https://practicaldermatology.com/issues/may-june-2025/leadership-without-authority-influencers-of-culture-in-your-practice/35924/Influencers in popular culture demonstrate how individuals without formal authority can shape trends, ideas, and behavior.2024 Tips: The Latest in Hair and Nails
https://practicaldermatology.com/topics/hair-nails/2024-tips-latest-hair-and-nails/26949/2024 Tips: The Latest in Hair and NailsAngioleiomyoma in a Rare Location
https://practicaldermatology.com/topics/other-dermatology/angioleiomyoma-in-a-rare-location/24012/A minimally invasive treatment is used to treat a tumor in a cosmetically sensitive area.Treatment of Psychodermatological Conditions Using N-acetylcysteine
https://practicaldermatology.com/columns/physician-spotlight/treatment-of-psychodermatological-conditions-using-n-acetylcysteine/23998/The low risk, high reward of NAC suggests its great promise in a supplementary role for treatment of trichotillomania and excoriation disorder.Pharma Sales 2.0
https://practicaldermatology.com/topics/practice-management/pharma-sales-20/23959/A behind-the-scenes look at how ReachRX aims to transform pharma sales and boost patient access.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-17/23343/Rosacea Update: A Closer Look at Zilxi
https://practicaldermatology.com/columns/clinical-focus-1/rosacea-update-a-closer-look-at-zilxi/23339/Inside the approval of Zilxi for moderate-to-severe facial papulopustular rosacea.Vitiligo: Oral and Topical JAKs Show Promise
https://practicaldermatology.com/topics/pigmentary-disorders/vitiligo-oral-and-topical-jaks-show-promise/23316/Early studies offer some hope for emerging therapies for repigmentation.